QuidelOrtho announced that Health Canada has approved for use in Canada the Quidel TriageTrue High-Sensitivity Troponin I Test on the Quidel Triage MeterPro, a high-performance, comprehensive testing platform with the smallest footprint analyzer, to aid in the diagnosis of myocardial infarction. The Quidel TriageTrue hsTnl Test effectively and safely offers fast turnaround time with a result within 20 minutes for quick decision-making for treatment.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on QDEL:
